Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.
Distler U, Souady J, Hülsewig M, Drmić-Hofman I, Haier J, Denz A, Grützmann R, Pilarsky C, Senninger N, Dreisewerd K, Berkenkamp S, Schmidt MA, Peter-Katalinic J, Müthing J.
Distler U, et al.
Mol Cancer Ther. 2008 Aug;7(8):2464-75. doi: 10.1158/1535-7163.MCT-08-0353.
Mol Cancer Ther. 2008.
PMID: 18723492